Report copyright - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · 7 In SPS and ZEST, the number of subjects who reported herpes zoster/herpes zoster-like rashes was less than 0.2% for ZOSTAVAX and placebo
Please pass captcha verification before submit form